4 articles found.
- The Effect of Darapladib Therapy for the Expression of Lp-PLA2 in Dyslipidemia and Type 2 Diabetes Mellitus Atherosclerosis Model
Titin Andri Wihastuti, Rosaria Dian Lestari, Teuku Heriansyah Journal of Applied Pharmaceutical Science. 2018; 8(4): 64-70. - Lp-PLA2 Selective Inhibitor (Darapladib) Effect in Lowering Insulin Resistance and Aortic Tissue Inflammation at Type 2 Diabetes Mellitus
Titin Andri Wihastuti, Dinda Zahra Putri Andiyani, Sri Andarini, Teuku Heriansyah Journal of Applied Pharmaceutical Science. 2017; 7(12): 110-115. - Effects of subchronic exposure of PSP Ganoderma lucidum on renal function and histopathology feature in Rattus novergicus Wistar strain
Titin Andri Wihastuti, Djanggan Sargowo, Mohammad Aris Widodo, Teuku Heriansyah, Setyowati Soeharto, Kenti Wantri Anita, Novita Qurrota Aini National Journal of Physiology, Pharmacy and Pharmacology. 2015; 5(4): 296-302. - Atherogenesis inhibition by darapladib administration in dyslipidemia model SpragueDawley rats
Teuku Heriansyah, Titin Andri Wihastuti, Kenty Wantri Anita, Agustin Iskandar, Riski Bagus Suhendra, Patan Ahmad Setiabudi, Lintang Widya Sishartami National Journal of Physiology, Pharmacy and Pharmacology. 2016; 6(1): 52-58.
|
|
|